Mother of Two's Battle with Rare 'Invisible' Cancer Exposes UK's Delayed Diagnoses
A mother of two from Buckinghamshire is grappling with a devastating diagnosis that has left her in a medical and emotional limbo. Kerie Ivory, 52, spent over a year battling symptoms she initially believed were minor — persistent coughing, acid reflux, and unrelenting fatigue — only to later learn they were signs of a rare, 'invisible' cancer. Her journey highlights a growing crisis in the UK, where delays in diagnosing neuroendocrine cancer are forcing patients into a cruel waiting game, with no immediate treatment options until tumors grow large enough to be addressed.
Ms. Ivory's struggle began with visits to her GP, where her concerns were repeatedly dismissed. 'I kept going back and forth to my GP, who dismissed my symptoms,' she recalled. 'By then I was so fatigued I was on my knees. I had to choose whether to eat or have a shower.' Her condition worsened until she was found to be anemic, a discovery that left her skeptical. 'I thought: "I am a healthy young woman, this cannot be it."' But the truth was far more insidious: neuroendocrine cancer, a type of tumor that often eludes early detection and is misdiagnosed as conditions like asthma or irritable bowel syndrome.
It took 15 months of persistent symptoms — including severe bloating, stomach pain, and an abdomen that would balloon from morning to evening — for doctors to investigate further. A colonoscopy finally revealed the culprit: a tumor blocking the path of the scope. 'I looked five months pregnant by the evening,' Ms. Ivory said, describing the disfiguring effects of the disease. The surgery that followed was extensive, requiring the removal of parts of her intestine, lymph nodes, and even sections of her liver and gallbladder. Yet, the relief of finally having a diagnosis came with an agonizing reality: the cancer had already spread, and treatment was contingent on tumor growth.
Neuroendocrine cancer, a group of rare tumors that arise from hormone-producing cells, often masquerades as more common conditions. It can develop in the stomach, lungs, or — as in Ms. Ivory's case — the bowel. Symptoms such as unexplained weight loss, fatigue, diarrhea, and heartburn are frequently attributed to less severe issues, delaying critical care. For Ms. Ivory, the disease has upended her life. She was forced to leave her job in 2022 due to the relentless fatigue, and her children now grapple with the knowledge that their mother's condition is a lifelong battle. 'My children have found it hard to accept — they understand it's never going away,' she said.
Statistics from Neuroendocrine Cancer UK (NCUK) paint a grim picture. The disease affects 6,000 people annually in England, with more than half diagnosed at an advanced stage. It takes an average of four years to secure a diagnosis, a timeline that has only worsened in recent decades. Analysis by NCUK shows a 371% increase in cases between 1995 and 2018 — far outpacing the rise of other cancers. For Ms. Ivory, this delay was compounded by a four-and-a-half-year gap between when the disease likely began and her 2012 diagnosis, which only occurred after she changed GPs.
The lack of immediate treatment options is particularly cruel. Unlike many cancers that can be aggressively addressed with surgery, chemotherapy, or radiation, neuroendocrine cancer often requires waiting for tumors to grow before intervention is possible. 'I am constantly waiting for the tumours to grow big enough to get treatment that is appropriate for me,' Ms. Ivory said. 'It's hard living with a slow-growing, creeping cancer. It's devastating knowing I have [it] and we are not treating it.' The uncertainty leaves patients in a psychological and physical purgatory, where they must endure the disease's progression without the relief of aggressive therapies.
Lisa Walker, CEO of NCUK, emphasized the urgent need for change. 'A key part of the challenge of neuroendocrine cancer is that it doesn't align with the common cancer narrative many expect,' she said. 'It doesn't act or look like more known cancers, and unlike others, it isn't always about recovery or decline. It often requires people to live with it for many years.' The charity's campaign for World Cancer Day aims to shift this narrative, urging public awareness of symptoms such as unintentional weight loss, persistent fatigue, and unexplained pain. Early recognition, they argue, could prevent the kind of prolonged suffering Ms. Ivory faces.
As Ms. Ivory continues to navigate her daily life with limitations that others might take for granted — like avoiding swimming pools to conserve energy — her story underscores a broader crisis. With every 90 minutes, a new diagnosis is confirmed, often at advanced stages where treatment options are scarce. For patients and families, the result is a burden that extends beyond physical health, leaving lasting emotional and financial scars. 'Delays to diagnosis and inconsistent care cause serious and lasting harm,' Walker said. 'Precious time is lost, allowing the cancer to progress before people receive the treatment they need.' In Ms. Ivory's case, the waiting game is not just a personal struggle — it is a call to action for a system that must do better to recognize and treat a disease that too often goes unseen.